Pharmacokinetic Tumor Heterogeneity as a Prognostic Biomarker for Classifying Breast Cancer Recurrence Risk.
Majid MahrooghyAhmed Bilal AshrafDania DayeElizabeth S. McDonaldMark RosenCarolyn MiesMichael D. FeldmanDespina KontosPublished in: IEEE Trans. Biomed. Eng. (2015)
Keyphrases
- breast cancer
- dce mri
- outcome prediction
- disease progression
- breast cancer patients
- early detection
- dynamic contrast enhanced mri
- logistic regression
- breast cancer diagnosis
- diagnosis of breast cancer
- computer aided diagnosis
- breast cancer detection
- computer aided detection
- risk management
- lung cancer
- cancer patients
- mammogram images
- gene expression data
- risk assessment
- survival analysis
- bladder cancer
- risk factors
- loss function
- text categorization
- decision trees